Inogent Laboratories Private Limited, a amalgamated private limited company, was established on 01 June 2005 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2005PTC046402. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹45.00 Cr and a paid-up capital of ₹16.13 Cr.
Employing 586 professional, Its leadership includes Venkata Krishna Reddy Gunupati (Director), Venkata Sanjayreddy Gunupati (Director), Davinder Singh Brar (Director). Past directors included Manmahesh Kantipudi, Shernaz Firoze Vakil. It holds no open charges and ₹105.00 Cr settled loans. Its latest AGM occurred on 17 July 2017, with the balance sheet filed on 31 March 2017. It is based at Plot 28A, Ida Nacharam,, Hyderabad, Telangana, 500076.
U24239TG2005PTC046402
046402
01 June 2005
₹45.00 Cr
₹16.13 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Inogent Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Krishna Reddy Gunupati | Director | 01 Jun 2005 | Current |
| Venkata Sanjayreddy Gunupati | Director | 01 Jun 2005 | Current |
| Davinder Singh Brar | Director | 30 Sep 2005 | Current |
| Manmahesh Kantipudi | Director | 14 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 20 Sep 2016 | Past |
| Pramod Abcsdd | Director | 29 Aug 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inogent Laboratories Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 26.07% increase. The company also saw a substantial improvement in profitability, with a 255.72% increase in profit. The company's net worth Soared by an impressive increase of 29.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Inogent Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,050,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jun 2016 | Others | ₹85.00 Cr | Satisfied |
| 03 Mar 2010 | Canara Bank | ₹20.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Inogent Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inogent Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inogent Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 17 Jun 2016 via Charge ID 100037913 with Others was fully satisfied on 17 Nov 2017. was documented.
Inogent Laboratories Private Limited last Annual general meeting of members was held on 17 Jul 2017 as per latest MCA records. was recorded as a recent event.
The activity Inogent Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad. was completed.
The activity A charge with Others of Rs. 85.00 Cr registered on 17 Jun 2016 with Charge ID 100037913 was modified on 22 Nov 2016. was completed.
Progress on A charge with Others amounted to Rs. 85.00 Cr with Charge ID 100037913 was registered on 17 Jun 2016. was documented.
Progress on A charge registered on 03 Mar 2010 via Charge ID 10208872 with Canara Bank was fully satisfied on 25 May 2016. was documented.
The CIN of Inogent Laboratories Private Limited is U24239TG2005PTC046402.
Inogent Laboratories Private Limited is headquartered at Plot 28A, Ida Nacharam,, Hyderabad, Telangana, 500076.
Inogent Laboratories Private Limited was incorporated on 01 June 2005.
The current directors of Inogent Laboratories Private Limited are
The primary industry of Inogent Laboratories Private Limited is Manufacturing.
Inogent Laboratories Private Limited is unlisted.
The authorized capital of Inogent Laboratories Private Limited is ₹45.00 Cr, and the paid-up capital is ₹16.13 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX